Analysts at Stifel Nicolaus Maintained their Past ‘Buy’ rating on Shares Alexion Pharmaceuticals Inc (NASDAQ:ALXN), Set a $245.00 Price Objective
Alexion Pharmaceuticals Inc (NASDAQ:ALXN) Rating Reaffirmed In analysts note made public on Friday, 11 December, The Buy rating of Alexion Pharmaceuticals Inc (NASDAQ:ALXN) shares was…
